Plaque - Cardiovascular Update

Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation

JAMA Cardiology

JULY 16, 2024

This study investigates the impact of lipoprotein(a) levels on long-term coronary artery plaque progression, high-risk plaque, and pericoronary adipose tissue inflammation.

Plaque

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

DAIC

JULY 18, 2024

a leader in non-invasive artificial intelligence (AI) heart care solutions, introduced the next generation HeartFlow Plaque Analysis with an interactive experience. Having access to a patient’s whole coronary picture, with both quantified plaque and physiology, is a game changer as a clinician. F.A.C.C.

Coronary Artery Disease

Coronary Artery Disease Plaque Technology Medicare

Vessel-Level Coronary Atherosclerotic Plaque Activity Predicts Myocardial Infarction Risk

Cardiology Update

JUNE 16, 2024

Recent research has illuminated the role of total coronary atherosclerotic plaque activity across the entire coronary arterial tree in predicting patient-level clinical outcomes. Vessel-level coronary atherosclerotic plaque activity was assessed using coronary 18 F-sodium fluoride positron emission tomography (PET). 3.72; P = 0.013).

Myocardial Infarction

Myocardial Infarction Plaque Coronary Artery Disease Research

Lp(a) and Coronary Plaque Progression

American College of Cardiology

JULY 24, 2024

What is the association of lipoprotein(a) (Lp[a]) levels with long-term coronary artery plaque progression, development of high-risk plaque, and pericoronary adipose tissue inflammation?

Plaque

Plaque Article

Very high LDL no impact on plaque progression

Dr. Malcolm Kendrick

DECEMBER 10, 2023

10th December 2023 A very important study – please watch Very high low density lipoprotein levels with no impact on plaque progression I interrupt my series on what is wrong with the health service to bring you breaking news. He states that five years is more than sufficient to detect any difference in plaque progression.

Plaque

Plaque Cholesterol Diet Diabetes

Plaque Psoriasis: Comorbidities, Classification, and Testing Practices

HCPLive

JUNE 25, 2024

Linda Stein Gold, MD, and Bruce Strober, MD PhD, discuss classification and monitoring practices for patients with plaque psoriasis.

Plaque

Atherosclerotic plaque stabilization and regression: a review of clinical evidence

Nature Reviews - Cardiology

JANUARY 3, 2024

Nature Reviews Cardiology, Published online: 04 January 2024; doi:10.1038/s41569-023-00979-8 In this Review, Sarraju and Nissen summarize the clinical trial evidence for coronary atherosclerotic plaque stabilization and regression with plasma LDL-cholesterol-lowering therapy and other treatments.

Plaque

Plaque Cholesterol

HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage

DAIC

JUNE 4, 2024

milla1cf Tue, 06/04/2024 - 20:54 June 4, 2024 — HeartFlow, a leader in cardiovascular healthcare technology, is pleased to announce a key Medicare policy development, which should allow for future expanded patient access to their Plaque Analysis product.

Medicare

Medicare Plaque Reimbursement Cardiovascular Disease

Physiology Friday #199: High-Intensity Interval Training Reduces Coronary Artery Plaque

Physiologically Speaking

JANUARY 5, 2024

In this 6-month randomized controlled study, twice-weekly HIIT reduced coronary plaque volume, increased aerobic fitness, and improved body composition in adults with stable heart disease, suggesting benefits for cardiovascular disease progression. Does this greater plaque presence put athletes at a greater risk of CVD events?

Plaque

Plaque Physiology Exercise Cholesterol

Higher Noncalcified Plaque Volume Is Associated With Increased Plaque Vulnerability and Vascular Inflammation

Circulation: Cardiovascular Imaging

JANUARY 11, 2024

BACKGROUND:Recently, it was reported that noncalcified plaque (NCP) volume was an independent predictor for cardiac events. Plaque volume was measured by computed tomography angiography, plaque vulnerability by optical coherence tomography, and the level of coronary inflammation by PCAT attenuation. versus 75.9%;P<0.001),

Plaque

Plaque Cardiovascular Imaging Cholesterol Circulation

Systemic Therapies for Plaque Psoriasis

HCPLive

JUNE 26, 2024

Dermatologists have a comprehensive discussion on systemic therapies for the treatment of plaque psoriasis, covering monitoring practices, and long term efficacy data for novel oral agent deucravacitinib.

Plaque

Preventive Percutaneous Coronary Intervention for High-Risk Coronary Plaques Reduces Cardiac Events

DAIC

APRIL 11, 2024

These new findings suggest that people with high-risk plaques that are likely to rupture could benefit from the procedure as a pre-emptive measure rather than waiting for a heart attack or other severe reduction in blood flow to occur. During PCI, an operator inserts a stent into a blocked artery through a catheter in the groin or arm.

Plaque

Plaque Heart Attack Heart attacks Coronary Artery Disease

Oral Systemics for the Treatment of Plaque Psoriasis

HCPLive

MARCH 13, 2024

Armstrong, MD, MPH, discusses emerging therapies in oral systemics for the treatment of plaque psoriasis and shares developments in TYK2 inhibition.

Plaque

Early Win for Preemptive Stents on Vulnerable Coronary Plaque

Med Page Today

APRIL 8, 2024

(MedPage Today) -- ATLANTA -- The concept of using stents to seal off non-flow-limiting vulnerable plaques, before they have a chance to rupture, worked out in the first major trial testing this provocative idea. Compared with standard medical.

Plaque

Plaque Stents Stent

The Evolving Role of Advanced Practice Providers Treating Plaque Psoriasis

HCPLive

MARCH 29, 2024

Dermatology physician assistants are talking about the evolving role of their profession in taking care of patients with plaque psoriasis.

Plaque

High-Risk Plaques on Coronary CTA: Correlation With OCT

American College of Cardiology

APRIL 12, 2024

Are high-risk plaque (HRP) features on coronary computed tomography angiography (CTA) associated with vulnerable plaque on optical coherence tomography (OCT)?

Plaque

Plaque Article

Coronary Atherosclerotic Plaque Activity and Risk of MI

American College of Cardiology

MAY 30, 2024

Is vessel-level coronary atherosclerotic plaque activity using coronary 18F-sodium fluoride positron emission tomography (PET) associated with patient vessel-level myocardial infarction (MI)?

Plaque

Plaque Myocardial Infarction Article

Protruding Aortic Plaque and Coronary Plaque Vulnerability

Journal of the American Heart Association

JANUARY 9, 2024

BackgroundProtruding aortic plaque is known to be associated with an increased risk for future cardiac and cerebrovascular events. Coronary plaque characteristics were compared to evaluate coronary plaque vulnerability in patients with protruding aortic plaque on computed tomography angiography.

Plaque

Plaque Aortic Myocardial Infarction Kidney Disease

New cardiovascular imaging approach provides a better view of dangerous plaques

Science Daily - Heart Disease

MARCH 5, 2024

Researchers have developed a new catheter-based device that combines two powerful optical techniques to image the dangerous plaques that can build up inside the arteries that supply blood to the heart.

Plaque

Plaque Cardiovascular Imaging Heart Attack Heart attacks

HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease

DAIC

MARCH 27, 2024

The registry will collect multi-site, real-world information on how the Plaque Analysis product provides enhanced patient insights, empowering physicians and helping to inform their medical management decisions for patients with suspected coronary artery disease (CAD). 2 “Data from the DECODE study shows the value of using Plaque Analysis.

Coronary Artery Disease

Coronary Artery Disease Plaque Technology Anatomy

Preventive Coronary Intervention on Stenosis With Functionally Insignificant Vulnerable Plaque

American College of Cardiology

APRIL 8, 2024

The goal of the PREVENT trial was to compare the safety and efficacy of medical therapy along with focal preventive PCI of non-flow-limiting vulnerable plaque compared with medical therapy alone.

Plaque

Plaque Stenosis Article

Beyond the Surface: Monitoring your Patients with Moderate to Severe Plaque Psoriasis

HCPLive

JUNE 26, 2024

A panel of dermatologists have a comprehensive discussion on exciting developments in the treatment of plaque psoriasis, focusing on treatment approaches, patient monitoring strategies, and recent clinical trial data.

Plaque

Plaque Psoriasis as a Systemic Disease

HCPLive

APRIL 5, 2024

Physician assistants TJ Chao and Kristine Kucera discuss how the understanding of plaque psoriasis has changed over time and is now considered a systemic disease.

Plaque

Fibroblast-like cells promote plaque stability in response to anti-IL-1? therapy

Nature Reviews - Cardiology

JANUARY 22, 2024

Nature Reviews Cardiology, Published online: 23 January 2024; doi:10.1038/s41569-024-00993-4 Anti-inflammatory therapy involving IL-1β inhibition might reduce the risk of cardiovascular events in individuals with clonal haematopoiesis by increasing the number of fibroblast-like cells in the fibrous cap region of atherosclerotic plaques, thereby stabilizing (..)

Plaque

Plaque Burden, Morphology and Flow â€“ Beyond the Lumen

American College of Cardiology

JUNE 18, 2024

Yancy, MD, MSc, MACC discuss insights from data and studies involving plaque burden, morphology and flow. In this interview, Andrew Choi, MD, FACC and Clyde W.

Plaque

Plaque Article

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

DAIC

MAY 23, 2024

a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study , highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal Cardiovascular Imaging. milla1cf Thu, 05/23/2024 - 08:00 May 23, 2024 — HeartFlow, Inc. ,

Plaque

Plaque Coronary Artery Disease Technology Anatomy

Mona Shahriari, MD: Evolving Role of Nonsteroidal Topicals in Plaque Psoriasis

HCPLive

JUNE 5, 2024

Mona Shahriari, MD, discusses the evolving role of nonsteroidal topical options the management of plaque psoriasis.

Plaque

Identification of microRNA biomarkers simultaneously expressed in circulating extracellular vesicles and atherosclerotic plaques

Frontiers in Cardiovascular Medicine

APRIL 24, 2024

The early detection of plaques by circulating biomarkers is highly clinically relevant to prevent the occurrence of major complications such as stroke or heart attacks. miRNA expression profiles of serum-derived EVs were obtained by small RNA sequencing and in plaque material simultaneously acquired from patients.

Plaque

Plaque Biomarkers Circulation Stenosis

Mona Shahriari, MD: Nonsteroidal Topicals Shift Treatment Paradigm in Plaque Psoriasis

HCPLive

JUNE 6, 2024

Mona Shahriari, MD, discusses how she foresees the role of nonsteroidal topical creams growing within the management of plaque psoriasis.

Plaque

Presence of microplastics in carotid plaques linked to cardiovascular events

Nature Reviews - Cardiology

MARCH 17, 2024

Nature Reviews Cardiology, Published online: 18 March 2024; doi:10.1038/s41569-024-01015-z In patients with carotid artery disease, the presence of microplastics and nanoplastics in the carotid plaque is associated with an increased risk of death or major cardiovascular events compared with patients in whom microplastics and nanoplastics were not detected. (..)

Plaque

Impact of Deucravacitinib on Plaque Psoriasis Treatment Landscape

HCPLive

MARCH 20, 2024

An expert in dermatologic conditions examines laboratory requirements for initiating deucravacitinib in patients with moderate-to-severe plaque psoriasis and the impact of deucravacitinib on the treatment landscape.

Plaque

Plaque Laboratory

Memory CD8 T cells promote pathogenic plaque buildup of the arteries in aged mice: Study

Medical Xpress - Cardiology

DECEMBER 13, 2023

Aging is known to be a risk factor for the biological changes that create the dangerous buildup of plaque in arteries called atherosclerosis, and aging also induces a buildup of memory CD8 T cells, a type of immune cell, in mice and humans.

Plaque

Plaque Atherosclerosis Risk Factors

Approaching Plaque Psoriasis Treatment in Difficult-to-Treat Areas

HCPLive

MARCH 27, 2024

An expert in dermatology provides insight on approaching treatment in patients with plaque psoriasis who have a low BSA involvement, but with symptoms that present in difficult-to-treat areas.

Plaque

The Oral Systemic Space of Plaque Psoriasis

HCPLive

APRIL 5, 2024

TJ Chao and Kristine Kucera, PA’s go into dept of the recent developments in the systemic oral space of plaque psoriasis.

Plaque

Selecting Appropriate Therapy in the Evolving Treatment Landscape of Plaque Psoriasis

HCPLive

APRIL 26, 2024

Expert dermatology physician assistants share how to select the appropriate therapy for your patient with plaque psoriasis in an expanding treatment landscape.

Plaque

Expression of miRNA-29c in the carotid plaque and its association with diabetic mellitus

Frontiers in Cardiovascular Medicine

FEBRUARY 4, 2024

Unfortunately, the reason for the build-up of atherosclerosis plaque is unknown. The miRNA-29c was reported to promote the phenotype transformation of vascular smooth muscle cells (VSMCs) in diabetes mice, eventually leading to plaque formation and bleeding. However, such studies are rare and limited to animal experiments.

Plaque

Plaque Diabetes Atherosclerosis Stroke

Exosomal circSCMH1/miR-874 ratio in serum to predict carotid and coronary plaque stability

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Background To investigate the correlation between lg (circSCMH1/miR-874) and acute coronary syndrome (ACS), acute myocardial infarction (AMI), and carotid plaque stability. Compared with the low-risk plaque and control groups, the lg (circSCMH1/miR-874) value of medium-high risk plaque group decreased ( P < 0.05).

Plaque

Plaque SCAD Coronary Artery Disease Myocardial Infarction

Mixed plaque on coronary CT angiography predicts atherosclerotic events in asymptomatic intermediate-risk individuals

Open Heart

MARCH 8, 2024

Objective Coronary CT angiography (CCTA) permits both qualitative and quantitative analysis of atherosclerotic plaque and may be a suitable risk modifier in assessing patients at intermediate risk of atherosclerotic cardiovascular disease. 47 (57%) patients had mixed plaque, which was predictive of MACE (OR 4.68 (95% CI 1.19

Plaque

Plaque Stenosis Cardiovascular Disease Stroke

Lumbar disc herniation is an independent predictor of plaque burden in the patients with unstable angina

Frontiers in Cardiovascular Medicine

FEBRUARY 8, 2024

Objective Assessing the impact of lumbar disc herniation (LDH) on the plaque burden of coronary atherosclerosis is our objective. Gensini scores were calculated to assess the plaque burden of coronary. The association between lumbar disc lesions grading and coronary plaque burden was analysed by Spearman's correlation test.

Plaque

Plaque Angina Myocardial Infarction Risk Factors

Overview of the Recent Development in the Treatment Landscape: Plaque Psoriasis

HCPLive

MARCH 29, 2024

Advances practice providers TJ Chao, MPAS, PA-C and Kristine Kucera, PA-C, MPAS, DHS discuss the recent development in the treatment landscape of plaque psoriasis.

Plaque

Focusing in on Novel Oral Systemic Therapies for Moderate Plaque Psoriasis: Medcast Video

HCPLive

MAY 21, 2024

Lauren Miller, MPAS, PA-C, leads an expert discussion surrounding exciting developments in the treatment landscape of plaque psoriasis.

Plaque

Patient Selection for Plaque Psoriasis Oral Systemic Treatments

HCPLive

MARCH 27, 2024

Armstrong comments on patient selection for oral systemic treatments for plaque psoriasis management. Dr April W.

Plaque

Using Deucravacitinib in Clinical Practice for Plaque Psoriasis Management

HCPLive

MARCH 20, 2024

Armstrong, MD, MPH, shares her experience using oral systemic treatments in clinical practice for the management of plaque psoriasis.

Plaque

PREVENT: Preventive PCI Superior to Optimal Medical Therapy Alone to Reduce Cardiac Events From Vulnerable Plaques

American College of Cardiology

APRIL 8, 2024

PCI performed preventively in patients with high-risk vulnerable plaques was found to be superior to optimal medical therapy alone in preventing a serious cardiac event, according to the results of the PREVENT trial, the largest study on preventive PCI to date, presented during a Late-Breaking Clinical Trial session during ACC.24

Plaque

Plaque Article

Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

Vessel-Level Coronary Atherosclerotic Plaque Activity Predicts Myocardial Infarction Risk

Lp(a) and Coronary Plaque Progression

Very high LDL no impact on plaque progression

Plaque Psoriasis: Comorbidities, Classification, and Testing Practices

Atherosclerotic plaque stabilization and regression: a review of clinical evidence

HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage

Physiology Friday #199: High-Intensity Interval Training Reduces Coronary Artery Plaque

Higher Noncalcified Plaque Volume Is Associated With Increased Plaque Vulnerability and Vascular Inflammation

Systemic Therapies for Plaque Psoriasis

Preventive Percutaneous Coronary Intervention for High-Risk Coronary Plaques Reduces Cardiac Events

Oral Systemics for the Treatment of Plaque Psoriasis

Early Win for Preemptive Stents on Vulnerable Coronary Plaque

The Evolving Role of Advanced Practice Providers Treating Plaque Psoriasis

High-Risk Plaques on Coronary CTA: Correlation With OCT

Coronary Atherosclerotic Plaque Activity and Risk of MI

Protruding Aortic Plaque and Coronary Plaque Vulnerability

New cardiovascular imaging approach provides a better view of dangerous plaques

HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease

Preventive Coronary Intervention on Stenosis With Functionally Insignificant Vulnerable Plaque

Beyond the Surface: Monitoring your Patients with Moderate to Severe Plaque Psoriasis

Plaque Psoriasis as a Systemic Disease

Fibroblast-like cells promote plaque stability in response to anti-IL-1? therapy

Plaque Burden, Morphology and Flow â€“ Beyond the Lumen

HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

Mona Shahriari, MD: Evolving Role of Nonsteroidal Topicals in Plaque Psoriasis

Identification of microRNA biomarkers simultaneously expressed in circulating extracellular vesicles and atherosclerotic plaques

Mona Shahriari, MD: Nonsteroidal Topicals Shift Treatment Paradigm in Plaque Psoriasis

Presence of microplastics in carotid plaques linked to cardiovascular events

Impact of Deucravacitinib on Plaque Psoriasis Treatment Landscape

Memory CD8 T cells promote pathogenic plaque buildup of the arteries in aged mice: Study

Approaching Plaque Psoriasis Treatment in Difficult-to-Treat Areas

The Oral Systemic Space of Plaque Psoriasis

Selecting Appropriate Therapy in the Evolving Treatment Landscape of Plaque Psoriasis

Expression of miRNA-29c in the carotid plaque and its association with diabetic mellitus

Exosomal circSCMH1/miR-874 ratio in serum to predict carotid and coronary plaque stability

Mixed plaque on coronary CT angiography predicts atherosclerotic events in asymptomatic intermediate-risk individuals

Lumbar disc herniation is an independent predictor of plaque burden in the patients with unstable angina

Overview of the Recent Development in the Treatment Landscape: Plaque Psoriasis

Focusing in on Novel Oral Systemic Therapies for Moderate Plaque Psoriasis: Medcast Video

Patient Selection for Plaque Psoriasis Oral Systemic Treatments

Using Deucravacitinib in Clinical Practice for Plaque Psoriasis Management

PREVENT: Preventive PCI Superior to Optimal Medical Therapy Alone to Reduce Cardiac Events From Vulnerable Plaques

Stay Connected